S100A8 and central nervous system disorder: We have validated the role of DA in the upregulation of the MRP8/14 heterodimer, both secreted and on the cell surface, via specific receptors, indicating that this may be a marker of CNS disorder in drug users, as well as a factor triggering replication in latent cells via binding to its receptor, RAGE, on infected cells.